Searchable abstracts of presentations at key conferences in endocrinology

ea0099p506 | Endocrine-Related Cancer | ECE2024

Primary hyperparathyroidism due to parathyroid cancer or atypical adenoma. a third-level spanish hospital experience

Malo Carolina Sanchez , Remigio Roberto Carlos Romo , Martin Salvago Maria Dolores Maria , Sendra Rodolfo Gonzalez , Garrido Maria Carmen Rosa

Parathyroid carcinoma (PC) is very rare and difficult to differentiate from atypical parathyroid adenoma (AA). En-bloc surgical resection is recommended, but most cases are diagnosed after non-radical surgery, and it is recommended to expand it. Given the rarity of the cases, the difficulty in the histological diagnosis (HD) and the unpredictability of the evolution, we analyzed our experience with PC and AA.Material and methods: We conducted a ...

ea0099ep405 | Adrenal and Cardiovascular Endocrinology | ECE2024

Adrenal lesions in in patients with MUTYH syndrome

de Carlos Joaquin , Zabalza Lucia , Irigaray Ana , Rosario Aznarez Maria , Yoldi Jon , Marti Miguel , Ayarza-Marien Xabier , Anda Apinariz Emma

Introduction: MUTYH (MutY homolog Escherichia coli, homolog of MYH, hMYH) is a repair enzyme with a crucial role in the correction of DNA errors, being considered a protective factor of the cell. MUTYH mutations have been linked to MUTYH-associated polyposis syndrome (MAP), an autosomal recessive disorder characterized by multiple colorectal adenomas. Patients with MAP show a much higher lifetime risk of gastrointestinal cancers as an additional role of MUTYH, it appears to co...

ea0099ep441 | Thyroid | ECE2024

Thyroid function in patients with MUTYH syndrome

de Carlos Joaquin , Zabalza Lucia , Irigaray Ana , Rosario Aznarez Maria , Oquinena Susana , Pineda Arribas Javier , Anda Apinariz Emma

Introduction: MUTYH (MutY homolog Escherichia coli, homolog of MYH, hMYH) is a repair enzyme with a crucial role in the correction of DNA errors, being considered a protective factor of the cell. MUTYH mutations have been linked to MUTYH-associated polyposis syndrome (MAP), an autosomal recessive disorder characterized by multiple colorectal adenomas. Patients with MAP show a much higher lifetime risk of gastrointestinal cancers as an additional role of MUTYH, it appears to co...

ea0081oc6.4 | Oral Communications 6: Endocrine-Related Cancer | ECE2022

Clinical correlates of a large Israeli cohort of Cys 618 Arg RET mutation

Chava Rosenblum Rachel , Hirsch Dania , Glasberg Simona , Benbassat Carlos , Yoel Uri , Ishay Avraham , Lamprecht Sagit Zolotov , Bachar Gideon , Banne Ehud , Twito Orit

Introduction: A syndrome of MEN2A and Hirschsprung’s disease described in Israeli Jews of Moroccan descent is caused by Cys 618 Arg mutation, one of the less common causes of MEN2A. We aimed to define the clinical characteristics of a large cohort with this mutation from a multi-center Israeli registry.Methods: The Israeli MTC registry including 8 centers was searched retrospectively for results of RET mutational analysis. Patients with a Cys 618 Ar...

ea0081ep279 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Malnutrition risk using morphofunctional evaluation in hematopoietic stem cell transplantation

Munoz Jimenez Concepcion , Teodomiro Carlos Alzas , Garcia-Ramirez Mireia , Romero Laura , Garcia Estefania , Jesus Calanas Continente Alfonso , Jose Molina Maria , Herrera-Martinez Aura D.

Background: Malnutrition affects 30-50% of patients with hematological malignancies; it is due to the disease itself, the treatment-related catabolic process and chemo-or radio-therapy side effects (nausea, vomiting, diarrhea and mucositis). Patients with poor nutritional status have increased morbidity (treatment complications, infections, mucositis) and mortality.AimTo evaluate the nutritional status of all patients that underwent hematopoietic stem ce...

ea0081ep841 | Pituitary and Neuroendocrinology | ECE2022

Descriptive study of the acromegaly disease activity according to ACRODAT® in a tertiary Hospital in Spain

Carlos Percovich Hualpa Juan , Anez Roberto , Centeno Rogelio Garci a , Fernandez Laura Gonzalez , Munoz Diego , Montenegro Alejandra Maricel Rivas , Fernandez Fernandez Elisa , Guerrero Crystal , Gonzalez Albarran Olga

Background: The goals of acromegaly treatment are to achieve long-term biochemical control, control tumor size and decrease the risk of developing systemic comorbidities. Moreover, from the patient’s perspective, symptoms and QoL are critical parameters of disease control and should be assessed routinely. To aid in the global clinical management of acromegaly, a holistic clinical decision support tool, the Acromegaly Disease Activity Tool (ACRODAT®) was developed.</p...

ea0081ep992 | Thyroid | ECE2022

Ectopic lingual thyroid presenting as massive bleeding in a high-risk surgical patient treated with radioactive iodine

De Carlos Joaquin , Pineda Jose Javier , Anda Emma , Toni Marta , Ollero Maria Dolores , Munarriz Patricia , Irigaray Ana , Ernaga Ander , Esparza Nerea

Introduction: Lingual thyroid ectopia is a rare congenital abnormality affecting embryogenesis of the gland descent from foregut through pre-tracheal region in the neck. Most cases have an asymptomatic course but may occasionally produce local obstructive symptoms. Diagnostic methods are 99mTc, 131I or 123I radionuclide scan, computed tomography scan, magnetic resonance, and ultrasound. Surgery is the elective treatment for cases presenting com...

ea0081ep998 | Thyroid | ECE2022

Thyroid disease in patients with type 1 diabetes

De Carlos Joaquin , Basterra Francisco Javier , Terreros Amaya Sainz De Los , Garcia Javier , Garcia Marta , Iriarte Ana , Marti Miguel , Jose Goni Maria

Introduction: An increased risk of thyroid disease (TD) has been described in patients with type 1 diabetes (DM1) with respect to the general population. The objective is to establish the incidence and characterize the differences in patients who develop TD in relation to the debut of DM1 (previous, concurrent or a posteriori).Materials and methods: Retrospective study of 1126 patients followed up in Endocrinology consultations in Navarra. Three types of...

ea0086oc4.2 | Adrenal and Cardiovascular | SFEBES2022

Generation of novel tools for the study and development of targeted therapeutic approaches for pheochromocytoma and paraganglioma

Kemkem Yasmine , Santambrogio Alice , Montibus Bertille , Abascal Sherwell Sanchez Carlos , Willis Thea L. , Lodge Emily J. , Yianni Val , Oakey Rebecca J. , Andoniadou Cynthia L.

Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumours, which arise from neural crest (NC)-derived structures: the adrenal medulla and the paraganglia. Around one third of PPGLs are associated with inherited cancer susceptibility genes, the highest rate among all tumour types. Currently, the only diagnostic criterion for malignant disease is the presence of metastasis and no molecular or histological features have been identified that help predict risk. A...

ea0090p619 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Pancreatic autoimmunity in the diagnosis of type 1 diabetes: usefulness of zinc transporter 8 and proposal for stepwise assessment

Rodriguez Escobedo Raul , Gonzalez Martinez Silvia , Alonso Felgueroso Carlos , Morales Sanchez Paula , Diaz Naya Lucia , Delgado Elias , Luis Menendez Torre Edelmiro

Introduction: Zinc transporter 8 (ZnT8) autoimmunity has been established as one of the markers for the diagnosis of type 1 diabetes (T1D) along with glutamate decarboxylase (GAD) and tyrosine phosphatase IA-2 (IA-2) antibodies. The aim of this study is to understand the status of pancreatic autoimmunity in the diagnosis of T1D, with special attention to the usefulness of ZnT8. In addition, as a second objective, we study the proposal to perform the assessment of pancreatic au...